COVID-19 Diagnostics Market Share Forecast to Witness Considerable Growth from 2020 to 2030

Since the COVID-19 has no therapeutic or preventive solution till date, testing is the only possible way currently to curb further spread of this infection. Companies have not only ramped up manufacturing of existing COVID-19 diagnostic products but are also conducting active research to introduce novel testing procedures, to further improve the efficiency & accuracy of these tests. The market for COVID-19 diagnostics is anticipated to be skyrocket in the coming months, as countries around the globe plan to amplify the number of tests being conducted significantly. The rapid spread of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can be primarily attributed to the growth of the global COVID-19 diagnostics market. The principal objective behind testing is to prevent further transmission of the virus and isolate individuals suffering from the infection. If testing, isolation, quarantining & social distancing norms are followed at an acceptable level, it would eventually segregate the infected population and restrict the further proliferation of the disease, till an effective therapeutic or preventive drug/vaccine is introduced. The diagnostic tests used to detect the COVID-19 includes molecular assays, serologic immunoassays and ancillary diagnostic tests. The molecular assay technique, which includes the RT-PCR-based assays, remains the cornerstone in COVID-19 diagnostic testing, owing to its high accuracy.

Major Key Players of the COVID-19 Diagnostics Market are:
Seegene Inc., F. Hoffmann-La Roche Ltd, altona Diagnostics GmbH, SD BIOSENSOR, Abbott, BIOMEDOMICS INC., Bio-Rad Laboratories, Inc., VivaChek Biotech (Hangzhou) Co., Ltd., Sensing Self, PTE. Ltd, Thermo Fisher Scientific, PerkinElmer Inc., among others.

Read More @ https://www.openpr.com/news/2061067/covid-19-diagnostics-market-share-forecast-to-witness